{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:26:10Z","timestamp":1788474370656,"version":"build-2803163510"},"reference-count":195,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,17]],"date-time":"2027-03-17T00:00:00Z","timestamp":1805241600000},"content-version":"am","delay-in-days":259,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000138","name":"U.S. Department of Education","doi-asserted-by":"publisher","award":["PA120A240033"],"award-info":[{"award-number":["PA120A240033"]}],"id":[{"id":"10.13039\/100000138","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000138","name":"U.S. Department of Education","doi-asserted-by":"publisher","award":["P120A210035"],"award-info":[{"award-number":["P120A210035"]}],"id":[{"id":"10.13039\/100000138","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000138","name":"U.S. Department of Education","doi-asserted-by":"publisher","award":["PO31S200104"],"award-info":[{"award-number":["PO31S200104"]}],"id":[{"id":"10.13039\/100000138","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000138","name":"U.S. Department of Education","doi-asserted-by":"publisher","award":["1T34GM15667-01"],"award-info":[{"award-number":["1T34GM15667-01"]}],"id":[{"id":"10.13039\/100000138","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000138","name":"U.S. Department of Education","doi-asserted-by":"publisher","award":["G-RISE 1T32GM152384-01"],"award-info":[{"award-number":["G-RISE 1T32GM152384-01"]}],"id":[{"id":"10.13039\/100000138","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["GT17833"],"award-info":[{"award-number":["GT17833"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R21CA240997-01A1"],"award-info":[{"award-number":["1R21CA240997-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1T34GM15667-01"],"award-info":[{"award-number":["1T34GM15667-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["DBG-23-1156894-01-ET"],"award-info":[{"award-number":["DBG-23-1156894-01-ET"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Coordination Chemistry Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ccr.2026.217778","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:42:04Z","timestamp":1773787324000},"page":"217778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Navigating the copper chelation highway: Tuning copper coordination chemistry for tumor control"],"prefix":"10.1016","volume":"559","author":[{"given":"Carmen","family":"Acosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Vega-Aponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Landrau-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina I.","family":"Marrero-Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Dur\u00e1n-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaritza","family":"Ortega-Avil\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra E.","family":"R\u00edos-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Conde","family":"Del Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambar I.","family":"Llanos De Jes\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando J.","family":"R\u00edos-Pad\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branlee Sang","family":"Laboy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella M.","family":"Gibson-Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Antomattei-Alejandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giam L.","family":"Bosques-Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry J.","family":"Cede\u00f1o-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizelis","family":"Ortiz-Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola N.","family":"Quesada-Oliveras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodo A.","family":"Hern\u00e1ndez-Iberri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Guerrero-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda V.","family":"Rivera-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur D.","family":"Tinoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2026.217778_bb0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbamcr.2016.01.026","article-title":"Redox cycling metals: pedaling their roles in metabolism and their use in the development of novel therapeutics","volume":"1863","author":"Kalinowski","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ccr.2026.217778_bb0010","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nchem.2381","article-title":"Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation","volume":"7","author":"Wang","year":"2015","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1011115820450","article-title":"DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases","volume":"15","author":"Ewing","year":"2001","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ccr.2026.217778_bb0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nmeth.1368","article-title":"Genetically encoded FRET sensors to monitor intracellular Zn2+ homeostasis","volume":"6","author":"Vinkenborg","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccr.2026.217778_bb0025","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1039\/C5MT00149H","article-title":"Targeting copper in cancer therapy: \u2018copper that cancer\u2019","volume":"7","author":"Denoyer","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/j.ccr.2026.217778_bb0030","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ccr.2026.217778_bb0035","article-title":"Recent advances in copper homeostasis-involved tumor theranostics","volume":"19","author":"Ren","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ccr.2026.217778_bb0040","doi-asserted-by":"crossref","first-page":"1555858","DOI":"10.3389\/fonc.2025.1555858","article-title":"Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma","volume":"15","author":"Liang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0045","doi-asserted-by":"crossref","first-page":"1209156","DOI":"10.3389\/fonc.2023.1209156","article-title":"Copper in cancer: from limiting nutrient to therapeutic target","volume":"13","author":"Tang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jinorgbio.2011.11.024","article-title":"Coordination chemistry of copper proteins: how nature handles a toxic cargo for essential function","volume":"107","author":"Rubino","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2026.217778_bb0055","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/ja00905a001","article-title":"Hard and soft acids and bases","volume":"85","author":"Pearson","year":"1963","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2026.217778_bb0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1039\/qr9571100381","article-title":"Ligand-field theory","volume":"11","author":"Griffith","year":"1957","journal-title":"Q. Rev. Chem. Soc."},{"key":"10.1016\/j.ccr.2026.217778_bb0065","series-title":"Copper: Inorganic & Coordination Chemistry, in: Encyclopedia of Inorganic Chemistry","author":"Conry","year":"2005"},{"key":"10.1016\/j.ccr.2026.217778_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1039\/c0mt00061b","article-title":"Cupredoxins--a study of how proteins may evolve to use metals for bioenergetic processes","volume":"3","author":"Choi","year":"2011","journal-title":"Metallomics"},{"key":"10.1016\/j.ccr.2026.217778_bb0075","doi-asserted-by":"crossref","first-page":"R421","DOI":"10.1016\/j.cub.2021.03.054","article-title":"Copper biology","volume":"31","author":"Tsang","year":"2021","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ccr.2026.217778_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12964-024-01726-3","article-title":"The crosstalk between copper-induced oxidative stress and cuproptosis: a novel potential anticancer paradigm","volume":"22","author":"Vo","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ccr.2026.217778_bb0085","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/bj20031174","article-title":"Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels","volume":"378","author":"Tapia","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.ccr.2026.217778_bb0090","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1039\/D3DT02166A","article-title":"Copper trafficking systems in cells: insights into coordination chemistry and toxicity","volume":"52","author":"Han","year":"2023","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ccr.2026.217778_bb0095","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.21037\/atm.2018.12.53","article-title":"Clinical practice guidelines in Wilson disease","volume":"7","author":"Saroli Palumbo","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0100","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.3390\/ijms23116249","article-title":"Lysyl oxidase family enzymes and their role in tumor progression","volume":"23","author":"Liburkin-Dan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccr.2026.217778_bb0105","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.3390\/cancers12123594","article-title":"The multifaceted roles of copper in Cancer: a trace metal element with dysregulated metabolism, but also a target or a bullet for therapy","volume":"12","author":"Leli\u00e8vre","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ccr.2026.217778_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051086","article-title":"Mutations in superoxide dismutase 1 (Sod1) linked to familial amyotrophic lateral sclerosis can disrupt high-affinity zinc-binding promoted by the copper chaperone for Sod1 (ccs)","volume":"25","author":"Boyd","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2026.217778_bb0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcat.2013.01.025","article-title":"Fenton-like copper redox chemistry revisited: hydrogen peroxide and superoxide mediation of copper-catalyzed oxidant production","volume":"301","author":"Pham","year":"2013","journal-title":"J. Catal."},{"key":"10.1016\/j.ccr.2026.217778_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijc.2910570122","article-title":"DNA base modifications in renal chromatin of wistar rats treated with a renal carcinogen, ferric nitrilotriacetate","volume":"57","author":"Toyokuni","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccr.2026.217778_bb0125","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3390\/pharmaceutics15092337","article-title":"Advancements in the application of the Fenton reaction in the Cancer microenvironment","volume":"15","author":"Ou","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ccr.2026.217778_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103256","article-title":"Deadly excess copper","volume":"75","author":"Sailer","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ccr.2026.217778_bb0135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4254\/wjh.v13.i6.634","article-title":"Wilson\u2019s disease: revisiting an old friend","volume":"13","author":"Lucena-Valera","year":"2021","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.ccr.2026.217778_bb0140","article-title":"Chronic copper sulfate poisoning","volume":"8","author":"Perestrelo","year":"2021","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0145","article-title":"She has the blues: an unusual case of copper sulphate intoxication","volume":"7","author":"Moussiegt","year":"2020","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0150","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/ijc.31991","article-title":"Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong liver Cancer cohort","volume":"144","author":"Fang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccr.2026.217778_bb0155","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/bjc.2017.1","article-title":"Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans","volume":"116","author":"Stepien","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccr.2026.217778_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213691","article-title":"Copper and colorectal cancer","volume":"16","author":"Ma\u0142yszko","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ccr.2026.217778_bb0165","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1177\/0300060518798507","article-title":"Association between serum copper levels and lung cancer risk: a meta-analysis","volume":"46","author":"Zhang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0170","article-title":"Copper-related genes predict prognosis and characteristics of breast cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccr.2026.217778_bb0175","article-title":"Copper depletion as a therapeutic strategy in cancer","volume":"19","author":"Lopez","year":"2019","journal-title":"Met. Ions Life Sci."},{"key":"10.1016\/j.ccr.2026.217778_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12011-017-1099-7","article-title":"Trace element and heavy metal levels in colorectal Cancer: comparison between cancerous and non-cancerous tissues","volume":"183","author":"Sohrabi","year":"2018","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0185","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/carcin\/bgx051","article-title":"Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European prospective investigation into Cancer and nutrition cohort","volume":"38","author":"Stepien","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ccr.2026.217778_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100522","article-title":"LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer","volume":"44","author":"Di Mauro","year":"2024","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0195","doi-asserted-by":"crossref","first-page":"ra56","DOI":"10.1126\/scisignal.2004870","article-title":"Memo is a copper-dependent redox protein with an essential role in migration and metastasis","volume":"7","author":"MacDonald","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ccr.2026.217778_bb0200","article-title":"Memo1 binds reduced copper ions, interacts with copper chaperone Atox1, and protects against copper-mediated redox activity in vitro","volume":"119","author":"Zhang","year":"2022","journal-title":"PNAS"},{"key":"10.1016\/j.ccr.2026.217778_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1209156","article-title":"Copper in cancer: from limiting nutrient to therapeutic target","volume":"13","author":"Tang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0210","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1073\/pnas.1910722117","article-title":"Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration","volume":"117","author":"Blockhuys","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.ccr.2026.217778_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112335","article-title":"Memo1 reduces copper-mediated reactive oxygen species in breast cancer cells","volume":"247","author":"Zhang","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2026.217778_bb0220","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cancers11050659","article-title":"Effects of copper chelation on BRAFV600E positive Colon carcinoma cells","volume":"11","author":"Baldari","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ccr.2026.217778_bb0225","first-page":"660","article-title":"BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies","volume":"6","author":"Clarke","year":"2015","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0230","doi-asserted-by":"crossref","first-page":"1900119","DOI":"10.1002\/adtp.201900119","article-title":"Lysyl oxidase Like-2 (LOXL2): an emerging oncology target","volume":"3","author":"Chopra","year":"2020","journal-title":"Adv. Therap."},{"key":"10.1016\/j.ccr.2026.217778_bb0235","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","article-title":"Mitochondrial metabolism promotes adaptation to proteotoxic stress","volume":"15","author":"Tsvetkov","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccr.2026.217778_bb0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.1179907","article-title":"Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation","volume":"327","author":"Alvarez","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ccr.2026.217778_bb0245","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2174\/092986712800609706","article-title":"Iron chelators for the treatment of cancer","volume":"19","author":"Yu","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0250","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/inorganics6040126","article-title":"Iron and copper intracellular chelation as an anticancer drug strategy","volume":"6","author":"Gaur","year":"2018","journal-title":"Inorganics"},{"key":"10.1016\/j.ccr.2026.217778_bb0255","doi-asserted-by":"crossref","first-page":"123004","DOI":"10.1016\/j.ica.2025.123004","article-title":"Advancing anticancer chelation therapy: insights from enhancing cytotoxic potency, targeted cellular delivery, metal-based immunomodulation, and combinatorial strategies","volume":"592","author":"Acosta","year":"2025","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ccr.2026.217778_bb0260","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9343(56)90066-3","article-title":"Penicillamine, a new oral therapy for Wilson's disease","volume":"21","author":"Walshe","year":"1956","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-2952(76)90210-0","article-title":"Studies on d-penicillamine metabolism in cystinuria and rheumatoid arthritis: isolation of S-methyl-D-penicillamine","volume":"25","author":"Perrett","year":"1976","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ccr.2026.217778_bb0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0049-0172(86)90022-3","article-title":"D-penicillamine: chemistry and clinical use in rheumatic disease","volume":"15","author":"Howard-Lock","year":"1986","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.ccr.2026.217778_bb0275","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0022-3476(88)83212-8","article-title":"Efficacy and toxicity of D-penicillamine in low-level lead poisoning","volume":"112","author":"Shannon","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ccr.2026.217778_bb0280","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.4049\/jimmunol.134.5.3371","article-title":"D-penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation","volume":"134","author":"Starkebaum","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.ccr.2026.217778_bb0285","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/anie.197503301","article-title":"D-Penicillamine--production and properties","volume":"14","author":"Weigert","year":"1975","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.ccr.2026.217778_bb0290","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1021\/ja00463a019","article-title":"Structure, properties, and function of a copper(I)-copper(II) complex of D-penicillamine: pentathallium(I) mu8-chloro-dodeca (D-penicillaminato)-octacuprate(I)hexacuprate(II) n-hydrate","volume":"99","author":"Birker","year":"1977","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2026.217778_bb0295","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jinorgbio.2006.12.007","article-title":"An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation","volume":"101","author":"Gupte","year":"2007","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2026.217778_bb0300","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1215\/S1152851704000869","article-title":"Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma","volume":"7","author":"Brem","year":"2005","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.ccr.2026.217778_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080852","article-title":"Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: clinical relevance","volume":"9","author":"Babak","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ccr.2026.217778_bb0310","first-page":"1121","article-title":"Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor","volume":"137","author":"Brem","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccr.2026.217778_bb0315","series-title":"U. Weill Medical College of Cornell (Ed.)","author":"Vahdat","year":"2005"},{"key":"10.1016\/j.ccr.2026.217778_bb0320","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1038\/s41467-021-27559-z","article-title":"Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis","volume":"12","author":"Ramchandani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccr.2026.217778_bb0325","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1078-0432.CCR-16-1326","article-title":"Influencing the tumor microenvironment: a phase II study of copper depletion using Tetrathiomolybdate in patients with breast Cancer at high risk for recurrence and in preclinical models of lung metastases","volume":"23","author":"Chan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50494-5","article-title":"High-affinity cu(I) chelator PSP-2 as potential anti-angiogenic agent","volume":"9","author":"Heuberger","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccr.2026.217778_bb0335","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000438485","article-title":"Behind the link between copper and angiogenesis: established mechanisms and an overview on the role of vascular copper transport systems","volume":"52","author":"Urso","year":"2015","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0340","article-title":"Endothelial cell tube formation assay for the in vitro study of angiogenesis","volume":"91","author":"DeCicco-Skinner","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ccr.2026.217778_bb0345","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.3390\/cancers14205122","article-title":"High-affinity cu(I)-Chelator with potential anti-tumorigenic action\u2014a proof-of-principle experimental study of human H460 Tumors in the CAM assay","volume":"14","author":"Heuberger","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ccr.2026.217778_bb0350","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1002\/anie.201807582","article-title":"Leveraging \u03b3-glutamyl transferase to direct cytotoxicity of copper Dithiocarbamates against prostate Cancer cells","volume":"57","author":"Bakthavatsalam","year":"2018","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.ccr.2026.217778_bb0355","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1158\/0008-5472.CAN-13-3527","article-title":"Copper signaling axis as a target for prostate cancer therapeutics","volume":"74","author":"Safi","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.741316","article-title":"Recent advances in repurposing disulfiram and disulfiram derivatives as copper-dependent anticancer agents","volume":"8","author":"Kannappan","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ccr.2026.217778_bb0365","doi-asserted-by":"crossref","first-page":"e2797","DOI":"10.1038\/cddis.2017.176","article-title":"Disulfiram\/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-\u03baB and Nrf2","volume":"8","author":"Xu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ccr.2026.217778_bb0370","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.2166","article-title":"Liposome encapsulated disulfiram inhibits NF\u03baB pathway and targets breast cancer stem cells in vitro and in vivo","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccr.2026.217778_bb0375","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature25016","article-title":"Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4","volume":"552","author":"Skrott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2026.217778_bb0380","series-title":"StatPearls","article-title":"Disulfiram","author":"Stokes","year":"2025"},{"key":"10.1016\/j.ccr.2026.217778_bb0385","doi-asserted-by":"crossref","first-page":"13896","DOI":"10.1039\/C9CC05438C","article-title":"A dithiocarbamate-based H2O2-responsive prodrug for combinational chemotherapy and oxidative stress amplification therapy","volume":"55","author":"Pan","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ccr.2026.217778_bb0390","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1039\/D2TB01150F","article-title":"Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis","volume":"10","author":"Lu","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ccr.2026.217778_bb0395","article-title":"New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccr.2026.217778_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.128222","article-title":"In-situ drug generation and controllable loading: rational design of copper-based nanosystems for chemo-photothermal cancer therapy","volume":"409","author":"Pan","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ccr.2026.217778_bb0405","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.7150\/thno.45558","article-title":"Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting","volume":"10","author":"Ren","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ccr.2026.217778_bb0410","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1021\/acs.molpharmaceut.3c01235","article-title":"Proving the antimicrobial therapeutic activity on a new copper\u2013thiosemicarbazone complex","volume":"21","author":"Fabra","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ccr.2026.217778_bb0415","doi-asserted-by":"crossref","first-page":"11297","DOI":"10.1021\/acs.inorgchem.1c01275","article-title":"Triapine analogues and their copper(II) complexes: synthesis, characterization, solution speciation, redox activity, cytotoxicity, and mR2 RNR inhibition","volume":"60","author":"Besleaga","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0420","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/acs.inorgchem.9b01281","article-title":"Synthesis, characterization, and in vitro anticancer activity of copper and zinc bis(thiosemicarbazone) complexes","volume":"58","author":"Anjum","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112258","article-title":"A new series of bioactive Mo(V)2O2S2-based thiosemicarbazone complexes: solution and DFT studies, and antifungal and antioxidant activities","volume":"245","author":"Cebotari","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2026.217778_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111620","article-title":"Antifungal activity of thiosemicarbazones, bis(thiosemicarbazones), and their metal complexes","volume":"225","author":"Bajaj","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2026.217778_bb0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.biopha.2016.12.112","article-title":"Thiosemicarbazones and Phthalyl-thiazoles compounds exert antiviral activity against yellow fever virus and Saint Louis encephalitis virus","volume":"87","author":"Pacca","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ccr.2026.217778_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111259","article-title":"Synthesis, characterization, computational assay and anti-inflammatory activity of thiosemicarbazone derivatives: highly potent and efficacious for COX inhibitors","volume":"126","author":"Saeed","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ccr.2026.217778_bb0445","article-title":"Thiosemicarbazone-based compounds: a promising scaffold for developing antibacterial, antioxidant, and anticancer therapeutics","volume":"30","author":"Czylkowska","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2026.217778_bb0450","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/jm301691s","article-title":"Alkyl substituted 2\u2032-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation","volume":"56","author":"Stefani","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0455","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/annonc\/mdn775","article-title":"Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma","volume":"20","author":"Nutting","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0460","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.leukres.2007.05.003","volume":"32","author":"Karp","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0465","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fonc.2019.01067","article-title":"Randomized phase II trial of Triapine-cisplatin-radiotherapy for locally advanced stage uterine cervix or vaginal cancers","volume":"9","author":"Kunos","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0470","doi-asserted-by":"crossref","first-page":"35768","DOI":"10.1074\/jbc.M112.396911","article-title":"Mechanistic studies of semicarbazone triapine targeting human ribonucleotide reductase in vitro and in mammalian cells: tyrosyl radical quenching not involving reactive oxygen species","volume":"287","author":"Aye","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0475","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jinorgbio.2011.07.003","article-title":"Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study","volume":"105","author":"Popovi\u0107-Bijeli\u0107","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2026.217778_bb0480","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00775-019-01675-0","article-title":"Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs","volume":"24","author":"Plamthottam","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0485","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/ars.2012.4540","article-title":"Novel chelators for cancer treatment: where are we now?","volume":"18","author":"Merlot","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ccr.2026.217778_bb0490","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s11696-021-02001-2","article-title":"Iron chelates in the anticancer therapy","volume":"76","author":"Szlasa","year":"2022","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ccr.2026.217778_bb0495","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1021\/jm00098a012","article-title":"Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiose micarbazone","volume":"35","author":"Liu","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0500","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1021\/acs.jmedchem.8b01996","article-title":"Novel Triapine derivative induces copper-dependent cell death in hematopoietic cancers","volume":"62","author":"Chen","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0505","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/1074-5521(95)90084-5","article-title":"Ribonucleotide reductases: radical enzymes with suicidal tendencies","volume":"2","author":"Stubbe","year":"1995","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ccr.2026.217778_bb0510","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.gendis.2022.11.022","article-title":"Ribonucleotide reductase M2 (RRM2): regulation, function and targeting strategy in human cancer","volume":"11","author":"Zuo","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.ccr.2026.217778_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101137","article-title":"The periodic table of ribonucleotide reductases","volume":"297","author":"Ruskoski","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1144269","article-title":"Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: a potential biomarker for hepatocellular carcinoma","volume":"13","author":"Qin","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0525","first-page":"3349","article-title":"RRM2 elicits the metastatic potential of breast cancer cells by regulating cell invasion, migration and VEGF expression via the PI3K\/AKT signaling","volume":"19","author":"Zhuang","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ccr.2026.217778_bb0530","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.7150\/jca.47895","article-title":"Independent prognostic implications of RRM2 in lung adenocarcinoma","volume":"11","author":"Ma","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.ccr.2026.217778_bb0535","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12935-020-01689-8","article-title":"RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer","volume":"20","author":"Yang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ccr.2026.217778_bb0540","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/ar4000407","article-title":"Reversible, long-range radical transfer in E. coli class Ia ribonucleotide reductase","volume":"46","author":"Minnihan","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0545","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1021\/bi034374r","article-title":"Pre-steady-state and steady-state kinetic analysis of E. Coli class I ribonucleotide reductase","volume":"42","author":"Ge","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ccr.2026.217778_bb0550","doi-asserted-by":"crossref","first-page":"14988","DOI":"10.1021\/ja0362095","article-title":"Pulsed ELDOR spectroscopy measures the distance between the two tyrosyl radicals in the R2 subunit of the E. Coli ribonucleotide reductase","volume":"125","author":"Bennati","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2026.217778_bb0555","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jinorgbio.2011.07.003","article-title":"Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study","volume":"105","author":"Popovi\u0107-Bijeli\u0107","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2026.217778_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00149","article-title":"Triapine radiochemotherapy in advanced stage cervical cancer","volume":"8","author":"Kunos","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0565","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2141.2009.07809.x","article-title":"Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival","volume":"146","author":"De Witte","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ccr.2026.217778_bb0570","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00432-017-2457-8","article-title":"Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?","volume":"143","author":"Mannargudi","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0575","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.leukres.2007.01.004","article-title":"Phase I and pharmacokinetic study of Triapine\u00ae, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies","volume":"31","author":"Gojo","year":"2007","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0580","article-title":"Phase I trial of Triapine\u2013cisplatin\u2013paclitaxel chemotherapy for advanced stage or metastatic solid tumor cancers","volume":"7-2017","author":"Kunos","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0585","article-title":"Triapine radiochemotherapy in advanced stage cervical cancer","volume":"8-2018","author":"Kunos","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0590","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/biom10091336","article-title":"Triapine derivatives act as copper delivery vehicles to induce deadly metal overload in Cancer cells","volume":"10","author":"Ohui","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ccr.2026.217778_bb0595","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1021\/acs.organomet.9b00229","article-title":"Redox-active organoruthenium(II)\u2013 and organoosmium(II)\u2013copper(II) complexes, with an amidrazone\u2013morpholine hybrid and [CuICl2]\u2212 as counteranion and their antiproliferative activity","volume":"38","author":"Ohui","year":"2019","journal-title":"Organometallics"},{"key":"10.1016\/j.ccr.2026.217778_bb0600","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1158\/1535-7163.MCT-05-0384","article-title":"A ferrous-Triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase","volume":"5","author":"Shao","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccr.2026.217778_bb0605","doi-asserted-by":"crossref","first-page":"12154","DOI":"10.1039\/D0NJ01070G","article-title":"Salicylaldehyde thiosemicarbazone copper complexes: impact of hybridization with estrone on cytotoxicity, solution stability and redox activity","volume":"44","author":"Petrasheuskaya","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0610","doi-asserted-by":"crossref","first-page":"4911205","DOI":"10.1155\/2022\/4911205","article-title":"Iron chelators in treatment of Iron overload","volume":"2022","author":"Entezari","year":"2022","journal-title":"J. Toxicol."},{"key":"10.1016\/j.ccr.2026.217778_bb0615","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400937","article-title":"Elucidating the high affinity copper(II) complexation by the Iron Chelator deferasirox provides therapeutic and toxicity insight","volume":"20","author":"Orta Rivera","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ccr.2026.217778_bb0620","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0003-9861(74)90298-7","article-title":"Structural implications derived from the analysis of electron paramagnetic resonance spectra of natural and artificial copper proteins","volume":"165","author":"Peisach","year":"1974","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ccr.2026.217778_bb0625","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1021\/jacsau.4c00774","article-title":"DefNEtTrp: an Iron dual Chelator approach for anticancer application","volume":"4","author":"Rodr\u00edguez","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.ccr.2026.217778_bb0630","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","article-title":"Cuproptosis: a copper-triggered modality of mitochondrial cell death","volume":"32","author":"Tang","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0635","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.freeradbiomed.2023.05.017","article-title":"Copper exerts cytotoxicity through inhibition of iron-sulfur cluster biogenesis on ISCA1\/ISCA2\/ISCU assembly proteins","volume":"204","author":"Du","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102139","article-title":"Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery","volume":"298","author":"Garza","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0645","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jinorgbio.2013.10.005","article-title":"Synthesis, crystallographic characterization and electrochemical property of a copper(II) complex of the anticancer agent elesclomol","volume":"130","author":"Vo","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2026.217778_bb0650","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-19873-2","article-title":"Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. \u03b1-lipoic acid as a potential anti-copper agent","volume":"8","author":"Smirnova","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccr.2026.217778_bb0655","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s12672-025-03421-2","article-title":"Copper-overload promotes ferroptosis in cervical cancer cells by upregulating HMOX1 expression","volume":"16","author":"Zhao","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0660","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1002\/1878-0261.13079","article-title":"Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A","volume":"15","author":"Gao","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12030524","article-title":"Disulfiram: mechanisms, applications, and challenges","volume":"12","author":"Lanz","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ccr.2026.217778_bb0670","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1039\/C4CC04767B","article-title":"On the interaction of copper(II) with disulfiram","volume":"50","author":"Lewis","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ccr.2026.217778_bb0675","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1021\/jm049568z","article-title":"Disulfiram facilitates intracellular cu uptake and induces apoptosis in human melanoma cells","volume":"47","author":"Cen","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0680","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an emerging target in Cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0685","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","article-title":"Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy","volume":"41","author":"Zheng","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0690","doi-asserted-by":"crossref","first-page":"1288504","DOI":"10.3389\/fonc.2023.1288504","article-title":"Cuproptosis: emerging biomarkers and potential therapeutics in cancers","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0695","doi-asserted-by":"crossref","first-page":"1290592","DOI":"10.3389\/fphar.2024.1290592","article-title":"Research progress on cuproptosis in cancer","volume":"15","author":"Feng","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ccr.2026.217778_bb0700","doi-asserted-by":"crossref","first-page":"1559236","DOI":"10.3389\/fphar.2025.1559236","article-title":"Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ccr.2026.217778_bb0705","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.7150\/ijbs.98806","article-title":"Elucidating the evolving role of cuproptosis in breast cancer progression","volume":"20","author":"Zhu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ccr.2026.217778_bb0710","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12935-024-03572-2","article-title":"Cuproptosis: a promising new target for breast cancer therapy","volume":"24","author":"Jiang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ccr.2026.217778_bb0715","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1016\/j.ymthe.2025.09.004","article-title":"Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemoresistance in PDAC","volume":"33","author":"Yu","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccr.2026.217778_bb0720","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.freeradbiomed.2025.01.042","article-title":"Identification of a novel cuproptosis inducer that induces ER stress and oxidative stress to trigger immunogenic cell death in tumors","volume":"229","author":"Ning","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0725","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/14756366.2017.1404591","article-title":"Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform","volume":"33","author":"Ning","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0730","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/inorganics9010007","article-title":"A structural survey of poly-functional Dithiocarbamate ligands and the aggregation patterns they sustain","volume":"9","author":"Lee","year":"2021","journal-title":"Inorganics"},{"key":"10.1016\/j.ccr.2026.217778_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118257","article-title":"Rational design of copper ionophores for efficient induction of cuproptosis via simple n-alkyl modification","volume":"301","author":"Yu","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0740","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.freeradbiomed.2018.09.017","article-title":"Designing salicylaldehyde isonicotinoyl hydrazones as cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells","volume":"129","author":"Ji","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0745","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36377-4","article-title":"Radiochemistry for positron emission tomography","volume":"14","author":"Rong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccr.2026.217778_bb0750","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.3390\/ijms22084159","article-title":"PET molecular imaging: a holistic review of current practice and emerging perspectives for diagnosis, therapeutic evaluation and prognosis in clinical oncology","volume":"22","author":"Duclos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccr.2026.217778_bb0755","article-title":"Positron emission tomography (PET)\/computed tomography (CT) imaging in radiation therapy treatment planning: a review of PET imaging tracers and methods to incorporate PET\/CT","volume":"8","author":"Trotter","year":"2023","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0760","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clinimag.2020.07.030","article-title":"A comprehensive review of dual-energy and multi-spectral computed tomography","volume":"67","author":"Garnett","year":"2020","journal-title":"Clin. Imaging"},{"key":"10.1016\/j.ccr.2026.217778_bb0765","series-title":"Clinical PET-CT in Radiology: Integrated Imaging in Oncology","first-page":"29","article-title":"Design and operation of combined PET-CT scanners","author":"Townsend","year":"2011"},{"key":"10.1016\/j.ccr.2026.217778_bb0770","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0377-1237(09)80099-3","article-title":"Clinical applications of PET and PET-CT","volume":"65","author":"Anand","year":"2009","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.ccr.2026.217778_bb0775","doi-asserted-by":"crossref","first-page":"368","DOI":"10.7861\/clinmedicine.12-4-368","article-title":"PET\/CT in oncology","volume":"12","author":"Ul-Hassan","year":"2012","journal-title":"Clin. Med. (Lond.)"},{"key":"10.1016\/j.ccr.2026.217778_bb0780","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/08998280.2005.11928089","article-title":"Use of pet\/Ct scanning in Cancer patients: technical and practical considerations","volume":"18","author":"Griffeth","year":"2005","journal-title":"Proc. (Baylor Univ. Med. Cent.)"},{"key":"10.1016\/j.ccr.2026.217778_bb0785","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/157340611796799177","article-title":"The development of copper radiopharmaceuticals for imaging and therapy","volume":"7","author":"Monica","year":"2011","journal-title":"Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0790","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1002\/mp.15524","article-title":"A feasibility study of the therapeutic application of a mixture of 67\/64Cu radioisotopes produced by cyclotrons with proton irradiation","volume":"49","author":"De Nardo","year":"2022","journal-title":"Med. Phys."},{"key":"10.1016\/j.ccr.2026.217778_bb0795","series-title":"Copper-64 Radiopharmaceuticals: Production, Quality Control and Clinical Applications","author":"I.A.E. Agency","year":"2022"},{"key":"10.1016\/j.ccr.2026.217778_bb0800","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/426892","article-title":"Radiopharmaceuticals in nuclear medicine: recent developments for SPECT and PET studies","volume":"2014","author":"Gutfilen","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ccr.2026.217778_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134158","article-title":"Chelation of theranostic copper radioisotopes with S-rich macrocycles: from radiolabelling of Copper-64 to in vivo investigation","volume":"27","author":"Tosato","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2026.217778_bb0810","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1021\/acs.jmedchem.4c02885","article-title":"Radiocopper in Radiopharmacy and medical use: current status and perspective","volume":"68","author":"Kr\u0119cisz","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0815","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1039\/C6DT00385K","article-title":"Improving the stability and inertness of cu(ii) and cu(i) complexes with methylthiazolyl ligands by tuning the macrocyclic structure","volume":"45","author":"Le Fur","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ccr.2026.217778_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.213923","article-title":"Well-defined organometallic copper(III) complexes: preparation, characterization and reactivity","volume":"442","author":"Liu","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ccr.2026.217778_bb0825","doi-asserted-by":"crossref","DOI":"10.1177\/1533033819830758","article-title":"64Cu-based radiopharmaceuticals in molecular imaging","volume":"18","author":"Zhou","year":"2019","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.ccr.2026.217778_bb0830","first-page":"379","article-title":"Copper-64 radiopharmaceuticals for PET imaging of Cancer: advances in preclinical and clinical research","volume":"24","author":"Anderson","year":"2009","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.ccr.2026.217778_bb0835","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semcancer.2022.12.011","article-title":"Tumor hypoxia: from basic knowledge to therapeutic implications","volume":"88","author":"Liao","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ccr.2026.217778_bb0840","series-title":"Inorganic Chemistry","author":"Housecroft","year":"2018"},{"key":"10.1016\/j.ccr.2026.217778_bb0845","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/acs.chemrev.8b00281","article-title":"Radioactive transition metals for imaging and therapy","volume":"119","author":"Boros","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ccr.2026.217778_bb0850","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1039\/C4DT02911A","article-title":"Radiometals: towards a new success story in nuclear imaging?","volume":"44","author":"Brasse","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ccr.2026.217778_bb0855","doi-asserted-by":"crossref","first-page":"16095","DOI":"10.1021\/acs.inorgchem.0c02314","article-title":"Is less more? Influence of the coordination geometry of copper(II) picolinate chelate complexes on metabolic stability","volume":"59","author":"Vaughn","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0860","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1021\/acscentsci.3c01050","article-title":"Radiochemistry: a hot field with opportunities for cool chemistry","volume":"9","author":"Bowden","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ccr.2026.217778_bb0865","series-title":"Radiopharmaceutical Chemistry","first-page":"335","article-title":"The radiopharmaceutical chemistry of the radioisotopes of copper","author":"Ling","year":"2019"},{"key":"10.1016\/j.ccr.2026.217778_bb0870","article-title":"64Cu-based radiopharmaceuticals in molecular imaging","volume":"18","author":"Zhou","year":"2019","journal-title":"TCRT"},{"key":"10.1016\/j.ccr.2026.217778_bb0875","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1158\/0008-5472.CAN-08-3781","article-title":"A novel technology for the imaging of acidic prostate tumors by positron emission tomography","volume":"69","author":"V\u0101vere","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2026.217778_bb0880","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1073\/pnas.1405240111","article-title":"Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer","volume":"111","author":"Viola-Villegas","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.ccr.2026.217778_bb0885","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.2967\/jnumed.114.146019","article-title":"Theranostic nanoparticles","volume":"55","author":"Chen","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0890","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors","volume":"20","author":"Dima","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ccr.2026.217778_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ccr.2026.217778_bb0900","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/ijms25031813","article-title":"Development of PET radioisotope Copper-64-Labeled Theranostic immunoliposomes for EGFR overexpressing Cancer-targeted therapy and imaging","volume":"25","author":"Jeong","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccr.2026.217778_bb0905","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ccr.2026.217778_bb0910","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12121964","article-title":"Enhanced permeability and retention effect as a ubiquitous and epoch-making phenomenon for the selective drug targeting of solid tumors","volume":"12","author":"Islam","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0915","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41565-018-0356-z","article-title":"Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness","volume":"14","author":"Peng","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ccr.2026.217778_bb0920","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2967\/jnumed.120.251579","article-title":"Therapeutic efficacy of a bivalent inhibitor of prostate-specific membrane antigen Labeled with 67Cu","volume":"62","author":"McInnes","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0925","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2967\/jnumed.118.217745","article-title":"64Cu-SARTATE PET imaging of patients with neuroendocrine Tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor radionuclide therapy","volume":"60","author":"Hicks","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2026.217778_bb0930","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3390\/molecules27051501","article-title":"67Cu production capabilities: a Mini review","volume":"27","author":"Mou","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2026.217778_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070772","article-title":"64Cu-SAR-bombesin PET-CT imaging in the staging of Estrogen\/progesterone receptor positive, HER2 negative metastatic breast cancer patients: safety, dosimetry and feasibility in a phase I trial","volume":"15","author":"Wong","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ccr.2026.217778_bb0940","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.5100","article-title":"COBRA: assessment of safety and efficacy of 64Cu-SAR-bisPSMA in patients with biochemical recurrence of prostate cancer following definitive therapy","volume":"42","author":"Nordquist","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccr.2026.217778_bb0945","author":"Pharmaceuticals"},{"key":"10.1016\/j.ccr.2026.217778_bb0950","author":"C. Pharmaceuticals"},{"key":"10.1016\/j.ccr.2026.217778_bb0955","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1039\/D4SC06969B","article-title":"Potential theranostics of breast cancer with copper-64\/67 sarcophagine-trastuzumab","volume":"16","author":"Rudd","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ccr.2026.217778_bb0960","doi-asserted-by":"crossref","first-page":"14055","DOI":"10.1038\/s41598-019-50494-5","article-title":"High-affinity cu(I) chelator PSP-2 as potential anti-angiogenic agent","volume":"9","author":"Heuberger","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccr.2026.217778_bb0965","author":"Wahner"},{"key":"10.1016\/j.ccr.2026.217778_bb0970","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccr.2026.217778_bb0975","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13550-021-00746-1","article-title":"A preliminary clinical trial to evaluate 64Cu-NOTA-trastuzumab as a positron emission tomography imaging agent in patients with breast cancer","volume":"11","author":"Lee","year":"2021","journal-title":"EJNMMI Res."}],"container-title":["Coordination Chemistry Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010854526002146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010854526002146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:44:20Z","timestamp":1778629460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010854526002146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":195,"alternative-id":["S0010854526002146"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2026.217778","relation":{},"ISSN":["0010-8545"],"issn-type":[{"value":"0010-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the copper chelation highway: Tuning copper coordination chemistry for tumor control","name":"articletitle","label":"Article Title"},{"value":"Coordination Chemistry Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2026.217778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217778"}}